Back
Arbutus Biopharma Vs. IperionX Industry Stock Comparison
Sell
37
ABUS
Arbutus Biopharma
Last Price:
$3.41
Seasonality Move:
17.59%
Buy
90
IPX
IperionX
Last Price:
$33.68
Seasonality Move:
35.72%
Sell
37
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
-
The current Arbutus Biopharma [ABUS] share price is $3.29. The Score for ABUS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.29The current trend is relatively stagnant and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
IPX Stock Price Chart
ABUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 41.81 | Sell |
Chaikin Money Flow: | -386325 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.23 - 3.61) | Sell |
Bollinger Bands (100): | (3.46 - 4.12) | Sell |
IPX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.12 | Buy |
Relative Strength Index (14 RSI): | 66.27 | Buy |
Chaikin Money Flow: | 28957 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.23 - 32.57) | Buy |
Bollinger Bands (100): | (17.72 - 28.34) | Buy |
ABUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.22 | Buy |
20-day SMA: | 3.42 | Sell |
50-day SMA: | 3.6 | Sell |
200-day SMA: | 3.46 | Sell |
8-day EMA: | 3.26 | Buy |
20-day EMA: | 3.36 | Sell |
50-day EMA: | 3.53 | Sell |
200-day EMA: | 3.43 | Sell |
IPX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.69 | Buy |
20-day SMA: | 30.19 | Buy |
50-day SMA: | 26.9 | Buy |
200-day SMA: | 18.76 | Buy |
8-day EMA: | 33.19 | Buy |
20-day EMA: | 30.78 | Buy |
50-day EMA: | 27.64 | Buy |
200-day EMA: | 20.19 | Buy |
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.06 per share.
IperionX Earnings Growth & IPX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.13 per share.
Arbutus Biopharma Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IperionX Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |